Aligning pharmacy and health-system objectives to eliminate central-line-associated bacteremias.
Lyles
Alan
A
School of Public Affairs, University of Baltimore, 1304 St. Paul Street, Baltimore, MD 21202, USA. calyles@ubalt.edu
Fanikos
John
J
Jewell
Kay
K
D000890:Anti-Infective Agents / Q000627:therapeutic use; D016470:Bacteremia / Q000382:microbiology / Q000517:prevention & control; D002404:Catheterization / Q000009:adverse effects; D002405:Catheterization, Central Venous / Q000009:adverse effects*; D003428:Cross Infection / Q000191:economics / Q000382:microbiology / Q000517:prevention & control*; D004339:Drug Compounding; D006040:Goals; D006760:Hospitalization / Q000191:economics; D006761:Hospitals; D006801:Humans; D010595:Pharmacists; D010607:Pharmacy Service, Hospital / Q000458:organization & administration*; D012307:Risk Factors; D012449:Safety
D000890:Anti-Infective Agents